Comparing Outcome of Thoracocentesis and Pigtail Catheter Drainage in Treatment of Patients With Hepatic Hydrothorax

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-20

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hepatic hydrothorax (HH) is a pleural effusion that develops in a patient with cirrhosis and portal hypertension in the absence of cardiopulmonary disease (Lv et al., 2018). Several factors are known to contribute to the development of effusion; the most accepted mechanism of which is the direct delivery of ascitic fluid from the peritoneal cavity to the pleural cavity by "positive" intra-abdominal pressure and a "negative" intrathoracic pressure of the pleural cavity through microscopic congenital diaphragmatic defects (Han et al., 2022).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy & Safety of Pigtail Catheter Drainage Versus Need Based Thoracocentesis for Recurrent Hepatic Hydrothorax.

NCT06007820

Hepatic Hydrothorax

UNKNOWN NA

Pigtail Catheter: a Less Invasive Option for Pleural Drainage of Recurrent Hepatic Hydrothorax

NCT02119169

Pleural Effusion

UNKNOWN NA

Thoracoscopic Mesh Repair of Diaphragmatic Defects for Hepatic Hydrothorax

NCT02508688

Liver Cirrhosis

COMPLETED NA

Empagliflozin as a Novel Therapy in Refractory Ascites

NCT05430243

Ascites Hepatic

COMPLETED PHASE2/PHASE3

PEriToneal Catheter Versus Repeated Paracentesis for Ascites in Cirrhosis

NCT03027635

Cirrhosis Ascites Hepatic Ascites (Non-Malignant)

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatic Hydrothorax

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

hepatic hydrothorax

patient with hepatic hydrothorax that develop pleural effusion either unilateral or bilateral

Group Type EXPERIMENTAL

Thoracocentasis

Intervention Type PROCEDURE

patients will be submitted to diagnostic pleural fluid study, chest x-ray, liver function and blood picture

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thoracocentasis

patients will be submitted to diagnostic pleural fluid study, chest x-ray, liver function and blood picture

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Pigtail Catheter drainage

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Liver cirrhosis (with or without hepatocellular carcinoma).
* Hepatic hydrothorax (bilateral or unilateral).

Exclusion Criteria

* patients with a pleural effusion due to a condition other than HH.
* who had a diagnosis of tuberculosis pleurisy, parapneumonic effusion, inflammatory pleuritis, other neoplasms, and congestive heart failure.

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes